Title : HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer.

Pub. Date : 2014 Sep 30

PMID : 25041784






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer. Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 CONCLUSION: HER2 overexpression in primary tumors might be a predictive marker for good efficacy of anthracycline-based neoadjuvant chemotherapy. Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens